D. CRAIG BRATER, M.D.; WILLIAM A. PETTINGER, M.D.
Approximately 40 states already have passed generic-drug substitution laws, and the Food and Drug Administration (FDA) and Federal Trade Commission have drawn up an "exemplary" bill as a model for state legislators interested in drafting similar laws and, presumably, for federal consideration. Various groups have aligned on different sides of this emotionally charged issue. We are facing the probability of legislative decisions more political than rational, decisions that ultimately could do more harm than good.
The aim of generic substitution laws is to reduce consumer costs through substitution of less expensive formulations for brand-name prescribed drugs. Almost everyone is interested
Learn more about subscription options.
Register Now for a free account.
BRATER DC, PETTINGER WA. The Generic Prescribing Issue. Ann Intern Med. 1980;92:426–427. doi: 10.7326/0003-4819-92-3-426
Download citation file:
Published: Ann Intern Med. 1980;92(3):426-427.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only